Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Keep an Eye on These 3 Revolutionary Cancer Treatments in 2014
Motley Fool
Friday, December 27, 2013 - 1:08pm
tags:
cancer, Roche, Infinity Pharmaceuticals, Inovio, Immunogen, Gilead Sciences, immunotherapy, antibody-drug conjugate
Weighing Out The Seattle Genetics Barbell
Seeking Alpha
Friday, December 27, 2013 - 1:03pm
tags:
Seattle Genetics, antibody-drug conjugate, Adcetris
The Race To Develop A Brain Cancer Treatment Takes An Interesting Turn
Forbes
Friday, December 27, 2013 - 1:01pm
tags:
brain cancer, glioblastoma multiforme, ImmunoCellular Therapeutics, Northwest Biotherapeutics, CytRx, Celldex Therapeutics, aldoxorubicin, DCVax
Roche: Some Companies Rebuild, This One Reloads
Motley Fool
Friday, December 27, 2013 - 12:18pm
tags:
Roche
Novartis to end manufacturing, supply agreement with Wright Medical unit
The Fly on the Wall
Friday, December 27, 2013 - 10:34am
tags:
Novartis, drug manufacturing, Wright Medical, BioMimetic Therapeutics
The Dark Side Of Big Pharma
Forbes
Friday, December 27, 2013 - 10:01am
tags:
Big Pharma, GSK, physician payments
The medtech tax will be repealed, and other predictions for 2014
Mass Device
Friday, December 27, 2013 - 9:59am
tags:
device tax, devices, IPOs, pelvic mesh
ANI Pharma says it bought 31 generic drugs from Teva from $12.5M upfront; ANI shares climb
Yahoo/AP
Friday, December 27, 2013 - 9:55am
tags:
generics, Teva, ANI Pharmaceuticals
Takeda Shares Drop After Scrapping Development of Diabetes Drug
Bloomberg
Friday, December 27, 2013 - 9:43am
tags:
Takeda, diabetes, TAK-875
AstraZeneca and Shionogi extend Crestor license
Reuters
Friday, December 27, 2013 - 9:42am
tags:
Crestor, AstraZeneca, Shionogi
Synergy Pharma Progresses with Plecanatide
Yahoo/Zacks.com
Friday, December 27, 2013 - 9:40am
tags:
Synergy Pharmaceuticals, plecanatide, IBS-C
How Will AstraZeneca Plc Fare In 2014?
Motley Fool, UK
Friday, December 27, 2013 - 9:37am
tags:
AstraZeneca
ALK announces FDA Advisory Committee to review ragweed sublingual AIT tablet
Yahoo
Friday, December 27, 2013 - 9:36am
tags:
advisory panels, FDA, ALK, Merck, ragweed
Shire Extends Tender Offer for ViroPharma
Yahoo
Friday, December 27, 2013 - 9:34am
tags:
Shire, ViroPharma, M&A
Jim Cramer: Ride the Four Horsemen of Biotech
TheStreet.com
Friday, December 27, 2013 - 9:34am
tags:
biotech, Biogen Idec, Celgene, Gilead Sciences, Regeneron
Cardiology in 2013: Like A Wrecking Ball
Forbes
Thursday, December 26, 2013 - 11:54pm
tags:
cardiology, Diovan, stem cells, Avandia, GSK, WATCHMAN, Novartis, Boston Scientific
Geron Corporation: The Best-Performing Biotechs of 2013
Motley Fool
Thursday, December 26, 2013 - 3:12pm
tags:
Geron
Wearable (Bolus) Injectors: The Next Big Thing In Drug Delivery
Seeking Alpha
Thursday, December 26, 2013 - 2:51pm
tags:
bolus injectors, devices, drug delivery, Insulet, Becton Dickinson, Unilife, West Pharmaceutical
InVivo Therapeutics to Move Forward with Its First Clinical Trial After Receiving FDA Conditional Approval
Yahoo
Thursday, December 26, 2013 - 2:47pm
tags:
devices, Invivo Therapeutics, degradable polymer scaffold, spinal cord injury, clinical trials
Idera Pharmaceuticals Presents a Promising Opportunity
Wall St Cheat Sheet
Thursday, December 26, 2013 - 2:45pm
tags:
Idera Pharmaceuticals, autoimmune disease, IMO-8400, IMO-9200, B cell lymphoma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.